Dr. Stefania Napolitano is a Postdoctoral Fellow at the University of Texas MD Anderson Cancer Center. She obtained an M.D. in the Specialty Program in Medical Oncology at the Second University of Naples. Apart from her clinical appointment at the Second University of Naples, she is also actively involved in translational and clinical research. She has mainly been studying preclinical models of intrinsic and acquired resistance to EGFR inhibitors in colorectal cancer and has gained expertise in basic research skills, including working with mouse models.